All Staphylococcus aureus articles
-
NewsNew Center of Excellence to respond to the challenge of antibiotic-resistant bacteria
Boston Children’s Hospital and Tulane University have received $25 million in funding from NIAID/NIH to establish a Center of Excellence for Translational Research (CETR) called IMPACT (Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity).
-
NewsAI uncovers hidden rules of some of nature’s toughest protein bonds
Scientists have shown how artificial intelligence can reveal the hidden rules of one of biology’s strangest phenomena: catch-bonds – molecular interactions that get stronger when pulled. Their findings shed light on how bacteria cling to surfaces, how tissues resist tearing, and how new biomaterials might be designed to harness force.
-
NewsMushroom chemical teams with phages to deliver a one-two punch to MRSA
A chemical found in mushrooms can be teamed with bacteriophages to deliver a one-two punch to antibiotic-resistant infections, reveals a study presented at MLS Future Forum 2025.
-
NewsThe cling of doom: How staph bacteria latch onto human skin
Scientists have discovered the strongest natural protein bond ever recorded, explaining how Staphylococcus aureus clings so tightly to human skin and pointing to new ways to fight antibiotic resistance.
-
NewsNew sepsis diagnostic could reduce critical time to save patients
A new diagnostic method would confirm sepsis infections earlier, cutting critical hours in the “race against time” to save patients’ lives. The process uses a centrifuge to separate bacteria from blood cells, and automatic microscopy for detection.
-
NewsResearchers use generative AI to design compounds that can kill drug-resistant bacteria
With help from artificial intelligence, researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).
-
NewsTwo-dose therapy for S. aureus bloodstream infections on par with standard treatment
A clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin seven days apart is just as good as daily IV doses of conventional antibiotics over four to six weeks.
-
NewsBee and frog proteins: nature’s double defense against farm superbugs
A new study reveals that combining natural antimicrobial peptides can significantly slow the development of antimicrobial resistance in bacteria. Using two peptides together prevents harmful bacteria from mutating as quickly, offering a promising alternative to traditional antibiotics.
-
NewsNew hydrogel-based treatment accelerates infected wound healing and balances skin microbiota
A novel ε-poly-L-lysine-loaded sodium-alginate/gelatin hydrogel (PSG15) has shown exceptional promise in accelerating the healing of infected wounds. The injectable hydrogel delivers antibacterial properties while regulating macrophage polarization and stabilizing the skin microbiota.
-
NewsLavender steps up as a natural preservative in skin-care emulsions
A new study shows that blends of lavender essential oil and hydrosol can replace synthetic preservatives in oil-in-water creams, cutting microbial counts by >99 % without irritating skin.
-
NewsSmart bandage with ‘plant power’ heals chronic wounds faster than market leaders
A multidisciplinary team has unveiled a next-generation wound dressing that behaves like a living leaf yet fights like a miniature pharmacy. It combines neomycin-grafted cellulose nonwovens with a polyvinyl alcohol/cellulose-nanofiber aerogel dyed with blueberry anthocyanins.
-
NewsBacteriostatic activity and mechanism of minerals containing rubidium
A new paper on traditional Chinese medicine outlines the bacteriostatic activity and mechanism of minerals containing rubidium (MCR).
-
NewsHidden bacterial redundancy could be antibiotic game-changer
Staphylococcus aureus possesses a surprising level of metabolic redundancy, allowing it to survive even when key enzymes are knocked out, a new study finds. However, when two specific enzymes are removed, staph doesn’t infect its host as readily.
-
NewsAI finds hundreds of potential antibiotics in snake and spider venom
Researchers used a deep-learning system to sift through a database of more than 40 million venom encrypted peptides (VEPs). In a matter of hours, the algorithm flagged 386 compounds with the molecular hallmarks of next-generation antibiotics.
-
NewsClove oil offers promise as antimicrobial alternative that could target healthcare-associated infections in low-income countries
A research study presented at MLS Future Forum 2025 has revealed that clove essential oil could offer potential as a sustainable alternative to conventional antimicrobials. While clove oil showed antibacterial and antifungal effects, turpentine oil had little antimicrobial activity.
-
NewsGreen light activates this antibiotic only where it’s needed
To make a more efficient antibiotic treatment, researchers have modified penicillin so that it’s activated only by green light. In early tests, the approach precisely controlled bacterial growth and improved survival outcomes for infected insects.
-
NewsSynthetic compound shows promise against multidrug resistance
Researchers have synthesized a new compound called infuzide that shows activity against resistant strains of pathogens. In lab and mouse tests, infuzide reduced bacterial populations, suggesting it might be useful as a new treatment for drug-resistant infections.
-
NewsResearchers reveal remarkable antimicrobial activity in hydrogen boride nanosheets
Hydrogen boride (HB) nanosheets represent an exciting new frontier in the search for technologies that can combat microbes in everyday settings. Researchers discovered that they exhibit excellent antibacterial, antiviral, and antifungal properties.
-
NewsNew molecular movie reveals how antibiotic resistance to fusidic acid works
Researchers revealed how FusB, a resistance protein found in clinically resistant strains of the bacterium Staphylococcus aureus, can rescue ribosomes from the antibiotic fusidic acid. FusB works like a molecular crowbar to free the blocked ribosome.
-
NewsSpiritual healing sites could be linked to antibiotic-producing microorganisms
A study by AMI member Dr Gerry Quinn highlights the potential of spiritual healing sites as fertile ground for novel antibiotics, particularly from Streptomyces bacteria, known for producing the majority of current antibiotics.